Testing effectiveness (Phase 2)Study completedNCT04357730
What this trial is testing
Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection
Who this might be right for
Severe Acute Respiratory SyndromeRespiratory FailureAcute Respiratory Distress Syndrome
Denver Health and Hospital Authority 50